Richard J. Kim - Jun 5, 2023 Form 4 Insider Report for AVADEL PHARMACEUTICALS PLC (AVDL)

Signature
/s/ Jerad G. Seurer, as Attorney-in-Fact
Stock symbol
AVDL
Transactions as of
Jun 5, 2023
Transactions value $
$0
Form type
4
Date filed
6/5/2023, 09:30 PM
Previous filing
Dec 9, 2021
Next filing
Mar 4, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVDL Stock Option (Right to Buy) Award $0 +175K $0.00 175K Jun 5, 2023 ADSs 175K $4.69 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On August 4, 2022, the Reporting Person was granted an option to purchase 175,000 ADSs, for which vesting was subject to the satisfaction of certain performance criteria. The performance criteria were met on June 5, 2023 (the "First Vesting Date"), resulting in the vesting of 50% of the ADSs underlying such option. The remaining ADSs will vest on the one year anniversary of the First Vesting Date, subject to the Reporting Person's continued service at such time.
F2 The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.